Skip to content

Assessment of using Extra Double J Stents complications in comparison with standard method.

Investigation of Urinary Symptoms, Biofilm Formation, and Encrustation in Extra Double J Stents compared to the Standard Method: A clinical trial

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20190624043991N38
Enrollment
80
Registered
2026-04-22
Start date
2026-09-23
Completion date
Unknown
Last updated
2026-06-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

kidney stone disease. Acute nephritic syndrome

Interventions

Intervention 1: Intervention group: In the intervention group, 40 patients will receive a double-loop double-J stent. A double-J stent is a stent with two loops extending outward from the midline of t

Sponsors

Tehran University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
Male
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: patients who needs treatment with Double J Stents Male sexuality Patients elder than 18 years old

Exclusion criteria

Exclusion criteria: Patients with active or systemic infection in urinary tract Patients who suffer from chronic kidney diseases Patients with history of complicated urethra surgery or anatomic abnormality that effect Double J Stents installation

Design outcomes

Primary

MeasureTime frame
Urinary tract symptoms (pain, irritation, urinary frequency & urgency). Timepoint: 3 , 7 and 14 days after placement of double J stent. Method of measurement: Ureteral Symptom Stent Questionnaire.

Secondary

MeasureTime frame
Biofilm formation. Timepoint: Days 3, 7, and 14 after placement of the Extra Double G stent. Method of measurement: Urine bacterial culture.;Analysis of mineral deposits. Timepoint: Days 3, 7, and 14 after placement of the Extra Double G stent. Method of measurement: FECal grading.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr Zahra Navi

Tehran University of Medical Sciences

shahrzadn951@gmail.com+98 21 6634 8593

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Jun 11, 2026